Erratum: Committee on infectious diseases. Recommendations for prevention and control of influenza in children, 2017 - 2018 (Pediatrics (2017) 140:4 (e20172550) DOI: 10.1542/peds.2017-2550);Recommendations for prevention and control of influenza in children, 2017-2018

Pediatrics

Volumn 140, Issue 4, 2017, Pages

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

INACTIVATED VACCINE; INFLUENZA VACCINE; OSELTAMIVIR; ZANAMIVIR;

ARTICLE; CAREGIVER; CHILD; DISEASE SEVERITY; DISEASE SURVEILLANCE; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG USE; EGG ALLERGY; HEALTH CARE AVAILABILITY; HEALTH CARE PERSONNEL; HEALTH CARE PLANNING; HEALTH PROMOTION; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); INFLUENZA VACCINATION; NONHUMAN; PEDIATRICIAN; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH CAMPAIGN; SEASONAL INFLUENZA; SYMPTOM; TREATMENT RESPONSE; UNITED STATES; UNIVERSAL PRECAUTION;

EID: 85030651433     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2017-3535     Document Type: Erratum

References (36)

1. Flannery B, Reynolds SB, Blanton L, et al. Influenza vaccine effectiveness against pediatric deaths: 2010-2014. Pediatrics. 2017;139(5):e20164244
2. Lessin HR, Edwards KM; Committee on Practice and Ambulatory Medicine; Committee on Infectious Diseases. Immunizing parents and other close family contacts in the pediatric office setting. Pediatrics. 2012;129(1). Available at: www. pediatrics. org/ cgi/ content/ full/ 129/ 1/ e247
3. Committee on Infectious Diseases. Policy statement: Influenza immunization for all health care personnel: Keep it mandatory. Pediatrics. 2015;136(4):809-818
4. American Academy of Pediatrics Committee on Pediatric Emergency Medicine; Frush K. Preparation for emergencies in the offices of pediatricians and pediatric primary care providers. Pediatrics. 2007;120(1):200-212
5. Edwards KM, Hackell JM; Committee on Infectious Diseases, The Committee on Practice and Ambulatory Medicine. Countering vaccine hesitancy. Pediatrics. 2016;138(3):e20162146
6. Committee on Practice and Ambulatory Medicine, Committee on Infectious Diseases, Committee on State Government Affairs, Council on School Health, Section on Administration and Practice Management. Medical versus nonmedical immunization exemptions for child care and school attendance. Pediatrics. 2016;138(3):e20162145
7. American Academy of Pediatrics, Committee on Infectious Diseases. Recommendations for prevention and control of influenza in children, 2016-2017. Pediatrics. 2016;138(4):e20162527
8. American Academy of Pediatrics Committee on Pediatric Emergency Medicine; American Academy of Pediatrics Committee on Medical Liability; Task Force on Terrorism. The pediatrician and disaster preparedness. Pediatrics. 2006;117(2):560-565
9. American Academy of Pediatrics. Influenza. In: Kimberlin DW, Brady MT, Jackson MA, Long SS, eds. Red Book: 2015 Report of the Committee on Infectious Diseases. 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015:476-493
10. Bradley JS, Blumer JL, Romero JR, et al. Intravenous zanamivir in hospitalized patients with influenza. Pediatrics. 2017, In press
11. Fiore AE, Fry A, Shay D, Gubareva L, Bresee JS, Uyeki TM; Centers for Disease Control and Prevention (CDC). Antiviral agents for the treatment and chemoprophylaxis of influenza - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2011;60(1):1-24
12. Grohskopf LA, Sokolow LZ, Broder KR, et al. Prevention and control of seasonal influenza with vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 influenza season. MMWR Recomm Rep. 2017;66(No. RR-2):1-20
13. Chan-Tack KM, Kim C, Moruf A, Birnkrant DB. Clinical experience with intravenous zanamivir under an emergency IND program in the United States (2011-2014). Antivir Ther. 2015;20(5):561-564
14. Englund JA, Walter EB, Fairchok MP, Monto AS, Neuzil KM. A comparison of 2 influenza vaccine schedules in 6- to 23-month-old children. Pediatrics. 2005;115(4):1039-104
15. Frey SE, Reyes MR, Reynales H, et al. Comparison of the safety and immunogenicity of an MF59-adjuvanted with a nonadjuvanted seasonal influenza vaccine in elderly subjects. Vaccine. 2014;32(39):5027-5034
16. Harper SA, Bradley JS, Englund JA, et al; Expert Panel of the Infectious Diseases Society of America. Seasonal influenza in adults and children-diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: Clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis. 2009;48(8):1003-1032 (Update forthcoming in 2017/2018)
17. Jefferson T, Jones MA, Doshi P, et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014;(4):CD008965
18. Iuliano AD, Jang Y, Jones J, et al. Increase in human infections with avian influenza A (H7N9) virus during the fifth epidemic - China, October 2016-February 2017. MMWR Morb Mortal Wkly Rep. 2017;66(9):254-255
19. Kelso JM, Greenhawt MJ, Li JT, et al. Adverse reactions to vaccines practice parameter 2012 update. J Allergy Clin Immunol. 2012;130(1):25-43
20. Kelso JM, Greenhawt MJ, Li JT; Joint Task Force on Practice Parameters (JTFPP). Update on influenza vaccination of egg allergic patients. Ann Allergy Asthma Immunol. 2013;111(4):301-302
21. Kimberlin DW, Acosta EP, Prichard MN, et al; National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza. J Infect Dis. 2013;207(5):709-720
22. McNeil MM, Weintraub ES, Duffy J, et al. Risk of anaphylaxis after vaccination in children and adults. J Allergy Clin Immunol. 2016;137(3):868-878
23. Pickering LK, Baker CJ, Freed GL, et al; Infectious Diseases Society of America. Immunization programs for infants, children, adolescents, and adults: Clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(6):817-840
24. Polyzos KA, Konstantelias AA, Pitsa CE, Falagas ME. Maternal influenza vaccination and risk for congenital malformations: A systematic review and meta-analysis. Obstet Gynecol. 2015;126(5):1075-1084
25. Robison SG, Osborn AW. The concordance of parent and child immunization. Pediatrics. 2017;139(5):e20162883
26. Rouphael NG, Paine M, Mosley R, et al; TIV-MNP 2015 Study Group. The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): A randomised, partly blinded, placebo-controlled, phase 1 trial. Lancet. 2017: 390(10095):649-658
27. Santos JJS, Finch C, Sutton T, et al. Development of an alternative modified live influenza B virus vaccine. J Virol. 2017;91(12):e00056-17
28. Sawyer MH, Simon G, Byington C. Vaccines and febrile seizures: Quantifying the risk. Pediatrics. 2016;138(1):e20160976
29. Sheffield JS, Greer LG, Rogers VL, et al. Effect of influenza vaccination in the first trimester of pregnancy. Obstet Gynecol. 2012;120(3):532-537
30. Shakib JH, Korgenski K, Presson AP, et al. Influenza in infants born to women vaccinated during pregnancy. Pediatrics. 2016;137(6):e20152360
31. Schlaudecker EP, Steinhoff MC, Omer SB, et al. IgA and neutralizing antibodies to influenza a virus in human milk: A randomized trial of antenatal influenza immunization. PLoS One. 2013;8(8):e70867
32. Shope TR, Walker BH, Aird LD, Southward L, McCown JS, Martin JM. Pandemic influenza preparedness among child care center directors in 2008 and 2016. Pediatrics. 2017;139(6):e20163690
33. South East Asia Infectious Disease Clinical Research Network. Effect of double dose oseltamivir on clinical and virological outcomes in children and adults admitted to hospital with severe influenza: Double blind randomised controlled trial. BMJ. 2013;346:f3039
34. Tran D, Vaudry W, Moore D, et al; Members of the Canadian Immunization Monitoring Program Active. Hospitalization for influenza A versus B. Pediatrics. 2016;138(3):e20154643
35. Uyeki TM. Influenza diagnosis and treatment in children: A review of studies on clinically useful tests and antiviral treatment for influenza. Pediatr Infect Dis J. 2003;22(2):164-177
36. Wang K, Shun-Shin M, Gill P, Perera R, Harnden A. Neuraminidase inhibitors for preventing and treating influenza in children (published trials only). Cochrane Database Syst Rev. 2012;(4):CD002744